Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Remote Assessments A Welcome Option For US FDA, But They’re Not Every Firm’s First Choice

Jul 28 2022

• By Hannah Daniel

• Source: Shutterstock

Related Content

Remote Inspections: Stakeholders Seek Clarity As Some At US FDA Struggle With Process

Feb 23 2022

Remote Site Visits Will Help US FDA Keep Reviews On Track During Remainder Of Pandemic

Apr 15 2021

US FDA Seeks Funding To Modernize Inspection-Related Technology Systems

Apr 20 2022

US FDA Assesses Over 500 Biopharma Plants Remotely Via Records Review; Refines Process

Sep 17 2020

US FDA Packages Suggestions To Amend DSHEA In Fiscal Year 2023 Budget Request

Mar 29 2022

House Appropriators Say Infant Formula Shortage Signals Restructuring Needed At US FDA

May 24 2022

US FDA Testing ‘Discount’ Multivitamins 'Very Soon’

Jul 25 2022

US FDA Explains How It Is Embracing Remote Assessments Post-Pandemic

Jul 25 2022

Additional Topics

United States FDA Regulation Guidance Documents Companies Compliance Dietary Supplements Drug Safety Policy Politics Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window